Business
Currency:CNY
2024/H1
Stock NameRevenueRatio
许可收入33.52M67.36%
销售眼科药物13.57M27.27%
销售眼科器械2.08M4.17%
独家分销权收入598K1.20%
Product
No Data
Region
Currency:CNY
2024/H1
Stock NameRevenueRatio
Chinese mainland48.71M97.88%
South Korea598K1.20%
Hong Kong (location)457K0.92%